Joaquin Duato
Joaquin Duato | |
|---|---|
 | |
| Born | 1962 (age 61–62) |
| Citizenship | Spain U.S. |
| Education | ESADE Business School (MBA) Thunderbird School of Global Management (Master of International Management) |
| Occupation | Businessman |
| Years active | 1989-present[1] |
| Title | Chairman and CEO of Johnson & Johnson |
| Term | 2022-present |
| Children | 2 |
Joaquin Duato (born April 1962) is a Spanish-American business executive. Duato is a dual citizen of Spain and the United States.[2] He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate.[3] He is the eighth person to be CEO of Johnson & Johnson since it became a publicly-traded company in 1944.
Early life and education
Duato grew up in Valencia, Spain. His career in health care was influenced by his family. His mother was a nurse, his grandfather was a pediatrician, and his grandmother a pharmacist. Duato speaks English, Spanish, and Italian. He received a Master of Business Administration from ESADE Business School in Barcelona, Spain, and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona.[4]
Career
In 1989, Duato began his career with Johnson & Johnson, joining Janssen Pharmaceuticals in Spain.[5] After moving to the USA in 2002, Duato was appointed Executive Vice President, Worldwide Chairman, Pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early 2000s.[4]
In 2018 when he was promoted to vice chairman of Johnson & Johnson’s executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations.[5][6] He also was interim Chief Information Officer.[4]
Duato was appointed CEO in August 2021 which became effective on January 3, 2022. He was also appointed to the company’s board of directors.[7][8] In November 2022, he was elected to chair the Board of Directors, effective January 2023. Duato oversaw the separation of Johnson & Johnson's consumer health segment, now an independent publicly traded company, Kenvue.[9]
During this time, Duato also was the executive sponsor of the company's African Ancestry Leadership Council.[10]
In 2023, Duato was the highest paid CEO of the major pharmaceutical companies, earning $28.4 million.That was a 117% increase over 2022.[11]
Board membership and honors
Joaquin Duato is a board member of the U.S. Spain Council and previously served on boards with UNICEF USA, Tsinghua University School of Pharmaceutical Sciences, and the Hess Corporation.[6] Duato was past chair of Pharmaceutical Research and Manufacturers of America (PhRMA).[6] Duato was Healthcare Businesswomen’s Association Honorable Mentor honoree and EVP in 2017.[12] In 2021, Duato was ranked #3 on the NJBIZ Manufacturing Power 50 list.[13] The following year, Duato received the 2022 ESADE Award.[14][15]
References
- ^ "5 Things to Know About Johnson & Johnson's New CEO Joaquin Duato". 16 June 2023. Retrieved 2023-06-16.
- ^ Rosenbaum, Eric (2022-03-30). "Next decade will transform health care more than past century: Johnson & Johnson CEO". CNBC. Retrieved 2022-06-15.
- ^ Nathan-Kazis, Josh. "J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition". www.barrons.com. Retrieved 2022-07-06.
- ^ a b c "The Architect of J&J's Breakup Bets on Tech for the Future of Drugs". Bloomberg.com. 2022-04-29. Retrieved 2022-06-15.
- ^ a b "A Look Inside J&J's Partnering & Innovation-Building Model". www.lifescienceleader.com. Retrieved 2022-06-15.
- ^ a b c "J&J CEO Steps Down, Taps Successor Joaquin Duato". BioSpace. Retrieved 2022-06-15.
- ^ Griffin, Riley (2021-08-19). "J&J's New Insider CEO Brings Expertise From Crucial Pharma Post". Bloomberg.com. Retrieved 2022-06-15.
- ^ "Johnson & Johnson adds vice chairman to leadership". nj. Associated Press. 2010-12-15. Retrieved 2022-06-15.
- ^ "J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation". Fortune. Retrieved 2023-11-17.
- ^ Rivas, Kayla (2021-08-20). "J&J's new CEO Joaquin Duato: What to know". FOXBusiness. Retrieved 2023-11-17.
- ^ "J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings".
- ^ "J&J's Joaquin Duato: Diversity is 'essential'". MM+M - Medical Marketing and Media. 2017-05-08. Retrieved 2022-06-15.
- ^ "Presenting the 2021 Manufacturing Power 50". NJBIZ. 2021-12-13. Retrieved 2022-06-15.
- ^ "Joaquín Duato, CEO of Johnson & Johnson, to Receive Esade Award - Esade". www.esade.edu. 2022-06-14. Retrieved 2023-11-17.
- ^ "Future, Inspiration and Lots of Networking at the 26th Esade Alumni Annual Meeting in Barcelona | ESADE Alumni". www.esadealumni.net. Retrieved 2023-11-17.